Report Store Get Proposal

Home Blog Notizia 40

Notizia - Recent Pharma, Healthcare and Biotech Happenings

recent-pharma-news-and-updates

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Birinapant licensing; AvantGen, IGM pairs up for anti-SARS-CoV-2 antibodies; BeiGene, Novartis to co-dvelop Tislelizumab; Valo raises USD190 M; Bluebird Bio Spins-off

Medivir, IGM Biosciences enters into an exclusive licensing agreement for Birinapant Medivir AB has entered into an exclusive licensing agreement with IGM Biosciences to receive global, exclusive development rights for Birinapant. Birinapant is a clinical-stage SMAC mimetic that degrades Inhibitors of Apoptosis Proteins (IAPs) by binding to them, ultimately leading to cell death in tumor cells. Further, Birinapant also complements the anti-tumor activity of the immune system. Thus, the drug appears to be a promising therapeutic agent in treating different forms of cancer in combination with other drugs. IGM-8444 is another drug that is currently being test...

Explore More...

BioGen

The Business Cocktail : Latest Pharma deals

transthyretin amyloidosis

CRISPR to cure sickle cell; FDA rejected; Stem cells use; Celgene spinoff

transthyretin amyloidosis

Symdeko’s approval; Erytech target solid tumors; Oncologie snapped bavituximab; Merck delivers

BioGen

Business Cocktail

transthyretin amyloidosis

Notizia

Default Blog Image

Business Cocktail

transthyretin amyloidosis

Notizia

transthyretin amyloidosis

Pandion bags $58M; Carmot Therapeutics grabs $15M; Innovent looks for IPO; Collaboration of Sandoz & Biocon

BioGen

Notizia

Default Blog Image

Adapsyn signed; Evolus filed; BioNTech signed a deal; Nordisk’s deal

transthyretin amyloidosis

Notizia

Default Blog Image

Business Cocktail

transthyretin amyloidosis

NOTIZIA

transthyretin amyloidosis

Regeneron/Sanofi’s PD-1 drug candidate; Zika targeting drugs and vaccines developments; CMO of Achillion will leave this month; Lincoln’s anti-malarial drug

transthyretin amyloidosis

Roche’s Phase 2 data; Celgene and Bluebird’s CAR-T therapy; Regeneron/Sanofi gets results; Allergan on women’s health

Entasis

December 7 Business Cocktail

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly